false
OasisLMS
Catalog
SCCM Resource Library
COVID-19 Disease and the Immune Response
COVID-19 Disease and the Immune Response
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Dr. Ken Remy discusses the immune response to COVID-19 and its impact on disease progression. He highlights the interplay between innate and adaptive immunity and their importance in defending against viral infections. The innate immune response is the first line of defense and involves cells such as macrophages, neutrophils, and natural killer cells. They secrete cytokines and chemokines to interfere with virus replication. The adaptive immune response, on the other hand, involves T cells and B cells. T cells recognize and kill infected cells, while B cells produce antibodies specific to the virus. Dr. Remy explains that COVID-19 can lead to immune suppression or overactivation, and this can result in a cytokine storm or immune exhaustion. He discusses the role of STAT3 signaling pathway and its potential as a therapeutic target. Dr. Remy also emphasizes the importance of precision medicine in tailoring therapies based on individual immune responses. Overall, understanding the complex immune response to COVID-19 is crucial for effective therapy administration and long-term immune consequences.
Asset Subtitle
Infection, Immunology, 2022
Asset Caption
This session will cover the current understanding of COVID-19-related immune response, including moderate and severe disease, plus immune response to vaccination.
Meta Tag
Content Type
Presentation
Knowledge Area
Infection
Knowledge Area
Immunology
Knowledge Level
Intermediate
Knowledge Level
Advanced
Membership Level
Select
Tag
Infectious Diseases
Tag
COVID-19
Year
2022
Keywords
immune response
COVID-19
disease progression
innate immunity
adaptive immunity
viral infections
×
Please select your language
1
English